Sanofi
Banafsheh Mehrazma, Vaccines Technologist at Sanofi's Toronto Campus, working with laboratory equipment while wearing protective gear including lab coat and purple gloves

Banafsheh Mehrazma, Technologist, Vaccines, Toronto Campus, Canada

Banafsheh Mehrazma, Technologist, Vaccines, Toronto Campus, Canada

First Quarter 2026

Q1 2026 results will be reviewed by management during a live audio webcast with the financial community today.

Learn more

Our Latest Articles

The F protein of the Respiratory Syncytial Virus (RSV), with a molecular clamp (purple) and key epitopes exposed (yellow).

Our Science

April 20, 2026

Shape Matters: Inside Molecular Clamp Vaccines

Two women in black wetsuits standing on a beach with a surfboard, ready for surfing

The Power of Chasing A Dream

Every day, we chase the miracles of science to improve people’s lives. We apply our deep understanding of the immune system to develop breakthrough innovations in medicines and vaccines so you can focus on what matters most, chasing your dreams. If you’re chasing your dreams, remember... you’re not alone. We’re right beside you

 

People Stories

We’re proud to spotlight those who inspire us to keep going further in the work we do.

A woman wearing a black wetsuit holds a surfboard under blue skies and sunshine while looking out to the horizon with a hopeful and determined expression.​

Céline, living with secondary progressive multiple sclerosis

France

We are an R&D driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth

About Us

Who We Are

We are an R&D driven,
AI-powered biopharma company committed to improving people’s lives and creating compelling growth.

Our Pipeline

5

Therapeutic areas

80

Compounds in clinical development

28

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases


April 23, 2026
Press Release: Q1 2026: double-digit sales and business EPS growth

April 22, 2026
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria

April 22, 2026
Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children

April 22, 2026
Press Release: Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US